文献速递乳房整形与再造创面修复

可吸收抗生素珠预防植入物乳房再造感染

Absorbable antibiotic bead prophylaxis for implant-based breast reconstruction.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2025-12-06

抗生素珠组与对照组在需再手术感染率(11.1% vs. 16.5%,p=0.46)和取出率(7.4% vs. 10.8%,p=0.59)上无显著差异;控制混杂因素后BMI与感染风险增加显著相关(OR 1.1,CI 1.04-1.14,p=.001);15例感染挽救手术中应用抗生素珠的总体成功率为86.7%(13例)。

要点

  • 高危患者预防性使用抗生素珠未显著降低再手术感染率或取出率。
  • BMI与感染风险增加独立相关(OR 1.1,CI 1.04-1.14,p=.001)。
  • 感染挽救手术中应用抗生素珠的总体成功率为86.7%(13/15)。

核心结论

  • 预防性抗生素珠可能降低高危植入物乳房再造患者的感染,但需前瞻性研究验证安全性和有效性。
  • 抗生素珠在感染后植入物挽救中可能特别有用。

研究设计与样本

  • 27例(9.4%)高危患者(BMI>30 kg/m2、吸烟史、糖尿病、放疗史)接受抗生素珠联合标准治疗,260例(90.6%)仅接受标准治疗。
  • 采用多因素logistic回归控制已知感染危险因素。

主要发现

  • 抗生素珠组与对照组需再手术感染率分别为11.1%和16.5%,差异无统计学意义(p=0.46)。
  • 抗生素珠组与对照组取出率分别为7.4%和10.8%,差异无统计学意义(p=0.59)。
  • 控制混杂因素后,BMI与感染风险增加显著相关(OR 1.1,CI 1.04-1.14,p=.001)。
  • 15例感染挽救手术中应用抗生素珠,总体成功率为86.7%(13例)。

临床怎么用

  • 高危患者(BMI>30 kg/m2、吸烟史、糖尿病、放疗史)可考虑在标准治疗基础上加用抗生素珠预防感染。
  • 感染后植入物挽救手术中可考虑应用抗生素珠以提高挽救成功率。

局限性

  • 回顾性研究设计,样本量有限(抗生素珠组仅27例)。
  • 单中心初步经验,需前瞻性研究进一步验证安全性和有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Periprosthetic infection is a serious complication in implant-based breast reconstruction (IBR). Local antibiotic delivery using biodegradable beads is a potential strategy to reduce infection risk. This study describes a single institution's preliminary experience with absorbable antibiotic beads for preventing infection in IBR. METHODS: A retrospective cohort study was performed of patients who underwent IBR between January 2021 and October 2023. Patients who met high-risk criteria for infection (BMI >30 kg/m2, prior smoking history, diabetes, and history of radiation) received antibiotic-infused beads along with the standard of care. Outcomes included periprosthetic infection, infection requiring re-operation, and wound-healing complications. Multivariate logistic regression was performed to control for known risk factors for infection. RESULTS: Two-hundred eighty-seven patients were included, with 27 (9.4%) receiving antibiotic beads and 260 (90.6%) receiving standard of care alone. No significant difference was observed in infection requiring re-operation between the antibiotic bead group compared to controls (11.1% vs. 16.5%, p=0.46), and no difference in explantation rate (7.4% vs. 10.8%, p=0.59). After controlling for confounders, BMI was significantly associated with increased odds of infection (OR 1.1 CI 1.04 - 1.14, p=.001). In patients who underwent salvage procedures for infection with the application of antibiotics beads (n=15), the overall salvage success rate was 86.7% (n=13). CONCLUSION: These data suggest that prophylactic antibiotic beads may reduce infections in high risk patients undergoing IBR. In addition, antibiotic beads may be particularly useful in the case of implant salvage for infection. Additional prospective studies are currently ongoing, and are needed to elucidate safety and efficacy.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Zhang C, Liu H, Liu SX, et al. Absorbable antibiotic bead prophylaxis for implant-based breast reconstruction. J Plast Reconstr Aesthet Surg. 2025. PMID: 41435804. doi:10.1016/j.bjps.2025.12.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。